Inhibikase Therapeutics (IKT) Price to Book Value: 1.369

Inhibikase Therapeutics, Inc. (IKT)

1.59 -0.04 (-2.45%) USD | NASDAQ | Oct 23, 16:00

1.585 0.00 (0.00%) After-Hours: 20:00

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.

Date	Value
October 23, 2026	1.369
October 22, 2026	1.404
October 21, 2026	1.429
October 20, 2026	1.472
October 19, 2026	1.416
October 16, 2026	1.421
October 15, 2026	1.576
October 14, 2026	1.55
October 13, 2026	1.516
October 12, 2026	1.589
October 09, 2026	1.696
October 08, 2026	1.645
October 07, 2026	1.671
October 06, 2026	1.705
October 05, 2026	1.722
October 02, 2026	1.722
October 01, 2026	1.662
September 30, 2026	1.770
September 29, 2026	1.739
September 28, 2026	1.765
September 25, 2026	1.774
September 24, 2026	1.808
September 23, 2026	1.851
September 22, 2026	1.989
September 21, 2026	1.894

Date	Value
September 18, 2026	1.981
September 17, 2026	1.981
September 16, 2026	1.989
September 15, 2026	1.989
September 14, 2026	2.058
September 11, 2026	2.015
September 10, 2026	2.006
September 09, 2026	2.075
September 08, 2026	2.092
September 04, 2026	2.153
September 03, 2026	2.17
September 02, 2026	2.153
September 01, 2026	2.049
August 31, 2026	1.989
August 28, 2026	2.075
August 27, 2026	2.127
August 26, 2026	2.144
August 25, 2026	2.153
August 24, 2026	2.153
August 21, 2026	2.058
August 20, 2026	2.024
August 19, 2026	2.110
August 18, 2026	2.067
August 17, 2026	2.058
August 14, 2026	2.075

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks